Treatment and outcomes of patients with chronic lung disease and acute myocardial infarction: Insights from the nationwide AMIS plus registry
European Journal of Clinical Investigation · 2024
DOI: 10.1111/eci.14193 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2024. Verfasst von C Beckmann und 8 weiteren Autor:innen. Beteiligte Einrichtung: AMIS Plus Data Center, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Registries, Hospital Mortality, Myocardial Infarction, Percutaneous Coronary Intervention. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Background
Limited data are available on patients with chronic lung disease (CLD) presenting with acute myocardial infarction (AMI). We aimed to analyse baseline characteristics, treatment and outcome of those patients enrolled in the Swiss nationwide prospective AMIS Plus registry.
Methods
All AMI patients enrolled between January 2002 and December 2021 with data on CLD, as defined in the Charlson Comorbidity Index, were included. The primary endpoints were in‐hospital mortality and major adverse cardiac and cerebrovascular events (MACCE), defined as all‐cause death, reinfarction and cerebrovascular events. Baseline characteristics, in‐hospital treatments and outcomes were analysed using descriptive statistics and logistic regression.
Results
Among 53,680 AMI patients enrolled during this time, 5.8% had CLD. Compared with patients without CLD, CLD patients presented more frequently with non‐ST‐elevation myocardial infarction (MI) and type 2 MI (12.8% vs. 6.5%, p < 0.001). With respect to treatment, CLD patients were less likely to receive P2Y12 inhibitors ( p < 0.001) and less likely to undergo percutaneous coronary interventions (68.7% vs. 82.5%; p < 0.001). In‐hospital mortality declined in AMI patients with CLD over time (from 12% in 2002 to 7.3% in 2021). Multivariable regression analysis showed that CLD was an independent predictor for MACCE (adjusted OR was 1.28 [95% CI 1.07–1.52], p = 0.006).
Conclusion
Patients with CLD and AMI were less likely to receive evidence‐based pharmacologic treatments, coronary revascularization and had a higher incidence of MACCE during their hospital stay compared to those without CLD. Over 20 years, in‐hospital mortality was significantly reduced in AMI patients, especially in those with CLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AMIS Plus Data Center, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
- Lung Center, Kantonsspital St. Gallen, St. Gallen, Switzerland.
- Department of Cardiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
- Division of Cardiology, Triemli Hospital, Zurich, Switzerland.
- Division of Cardiology, Geneva University Hospitals, Geneva, Switzerland.
- Department of Cardiology, Cardiocentro Ticino, Lugano, Switzerland.
ORCID-Profile: C Beckmann, M T Maeder, M Roffi
Zitieren
APA
Beckmann, C., Foster-Witassek, F., Brutsche, M., Maeder, M. T., Eberli, F., Roffi, M., Pedrazzini, G., Radovanovic, D., & Rickli, H. (2024). Treatment and outcomes of patients with chronic lung disease and acute myocardial infarction: Insights from the nationwide AMIS plus registry. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14193
Vancouver
Beckmann C, Foster-Witassek F, Brutsche M, Maeder MT, Eberli F, Roffi M, et al. Treatment and outcomes of patients with chronic lung disease and acute myocardial infarction: Insights from the nationwide AMIS plus registry. European Journal of Clinical Investigation. 2024. doi:10.1111/eci.14193
BibTeX
@article{Beckmann2024,
author = {Beckmann, C and Foster-Witassek, F and Brutsche, M and Maeder, M T and Eberli, F and Roffi, M and Pedrazzini, G and Radovanovic, D and Rickli, H},
title = {Treatment and outcomes of patients with chronic lung disease and acute myocardial infarction: Insights from the nationwide AMIS plus registry},
journal = {European Journal of Clinical Investigation},
year = {2024},
doi = {10.1111/eci.14193}
}
EUVIMED